Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.887% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] Cc1c(C#N)c2ccccc2n1C
[b] O=C(N/N=C/c1ccccn1)c1cc(-c2ccc(Br)s2)[nH]n1
[c] COc1ccc(CN(C)C(=O)c2ccccc2Sc2ccccc2C#N)c(OC)c1
Answer: c. COc1ccc(CN(C)C(=O)c2ccccc2Sc2ccccc2C#N)c(OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CN(C)C(=O)c2ccccc2Sc2ccccc2C#N)c(OC)c1
COc1ccc(CN(C)C(=O)c2ccccc2Sc2ccccc2C#N)c(OC)c1
2-(2-cyanophenyl)sulfanyl-N-[(2,4-dimethoxyphenyl)methyl]-N-methylbenzamide